Product NDC: | 0409-4921 |
Proprietary Name: | Epinephrine |
Non Proprietary Name: | EPINEPHRINE |
Active Ingredient(s): | .1 mg/mL & nbsp; EPINEPHRINE |
Administration Route(s): | ENDOTRACHEAL; INTRACARDIAC; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4921 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 19850405 |
Package NDC: | 0409-4921-34 |
Package Description: | 10 CARTON in 1 PACKAGE (0409-4921-34) > 1 SYRINGE in 1 CARTON > 10 mL in 1 SYRINGE |
NDC Code | 0409-4921-34 |
Proprietary Name | Epinephrine |
Package Description | 10 CARTON in 1 PACKAGE (0409-4921-34) > 1 SYRINGE in 1 CARTON > 10 mL in 1 SYRINGE |
Product NDC | 0409-4921 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EPINEPHRINE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | ENDOTRACHEAL; INTRACARDIAC; INTRAVENOUS |
Start Marketing Date | 19850405 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Hospira, Inc. |
Substance Name | EPINEPHRINE |
Strength Number | .1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |